Analysis showed that PRMT3-mediated tumorigenesis was HIF1α methylation-dependent. A novel therapeutic molecule (MPG-peptide) was used to inhibit HIF1α expression.
[Cell Death & Disease]
Sorry, but the selected Zotpress account can't be found.
Sorry, but the selected Zotpress account can't be found.